AwardTape · Defense awards · Research and development · Health R&D · W81XWH20C0030
W81XWH20C0030: $49.4M definitive contract to Cellphire, Inc
Cellphire, Inc holds a definitive contract from Defense Health Agency with $49.4M obligated since Oct 2023 and $70.3M obligated over its life, against a ceiling of $73.6M. Latest action Apr 14, 2026.
Cryopreserved platelet (cpp) development for us fda licensure
| PIID | W81XWH20C0030 |
|---|---|
| Type | definitive contract |
| Company | Cellphire, Inc |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Research and development · Health R&D |
| PSC | AN94 OTHER MEDICAL (ENGINEERING) |
| NAICS | 541715 RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| Obligated since Oct 2023 | $49.4M |
| Total obligated (lifetime) | $70.3M |
| Ceiling (base and all options) | $73.6M |
| Base date | Dec 20, 2019 |
| Latest action | Apr 14, 2026 |
| End date | Oct 31, 2028 |
| Actions since Oct 2023 | 9 |
| Pricing | Cost plus fixed fee |
| Competition | Competed after exclusion of sources |
| Place of performance | MD |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial